Contact Us

Dr. Scott Gottlieb says Hillary Clinton’s plan to lower drug costs is ‘misdirected’

September 30, 2015
Source: Link

(Original source Becker’s Hospital Review)

“Democratic presidential candidate Hillary Clinton’s plan to focus on the “price gouging” by pharmaceutical companies and the need for price regulation will only lead the industry further astray, according to Scott Gottlieb’s, MD, recent article in The Wall Street Journal.

“What [Ms. Clinton] fails to comprehend is that the high drug prices she decries aren’t the result of market forces gone wild. Rather, they are the result of bad regulation that has created market failures and shortages,” Dr. Gottlieb, a physician and resident fellow at the American Enterprise Institute, wrote in the WSJ.”

Click here to read more

Subscribe to the WWSG newsletter.

Check Availability

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Speaker List
Share My List